Summary
The publisher, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Greece”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Greece. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.
The Greek pharmaceutical market decreased from $9.5B in 2011 to $7.3B in 2018 at a Compound Annual Growth Rate (CAGR) of -3.6%. The overall market is forecast to be $6.7B in 2025. The reduction in drug prices and a decrease in public health expenditure has adversely affected the pharmaceutical market. The Greek medical devices market was $1.27B in 2015, which increased at a CAGR of 2.9% to reach $1.43B in 2019. The market is expected to grow at a CAGR of 3.1% from $1.47B in 2020 to $1.7B in 2025. The Greek pharmaceutical industry is undergoing major transformation. The Hellenic Association of Pharmaceutical Companies (SFEE) has designed and introduced a medium-term (2014-2021) Strategic Action Plan for the industry. The strategy aims to make Greece a hub for clinical research, while increasing employment and R&D expenditure.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Greece, and includes -
Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
The publisher, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Greece”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Greece. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.
The Greek pharmaceutical market decreased from $9.5B in 2011 to $7.3B in 2018 at a Compound Annual Growth Rate (CAGR) of -3.6%. The overall market is forecast to be $6.7B in 2025. The reduction in drug prices and a decrease in public health expenditure has adversely affected the pharmaceutical market. The Greek medical devices market was $1.27B in 2015, which increased at a CAGR of 2.9% to reach $1.43B in 2019. The market is expected to grow at a CAGR of 3.1% from $1.47B in 2020 to $1.7B in 2025. The Greek pharmaceutical industry is undergoing major transformation. The Hellenic Association of Pharmaceutical Companies (SFEE) has designed and introduced a medium-term (2014-2021) Strategic Action Plan for the industry. The strategy aims to make Greece a hub for clinical research, while increasing employment and R&D expenditure.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Greece, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: GlaxoSmithKline, Lavipharm, Novartis, Pfizer, and Sanofi
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Alcon, GE Healthcare, Fresenius, and Roche Diagnostics
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Greek healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Greece’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Greece’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
1 Table of Contents
2. Executive Summary
3. Overview of Pharmaceutical Market
4. Overview of Medical Devices Market
5. Pharmaceutical and Medical Devices Market-Drivers and Barriers
6. Deal Analysis
7. HealthTech Landscape
8. Market Access
9. Country Healthcare Landscape
13. Appendix
List of Tables
List of Figures
